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During renal fibrogenesis, tubular epithelial–mesenchymal
transition is closely associated with peritubular inflammation;
however, it is not clear whether these two processes
are connected. We previously identified the inhibitor of
differentiation-1 (Id1), a dominant negative antagonist of
basic helix–loop–helix transcription factors, as a major trigger
of tubular cell dedifferentiation after injury. Id1 was induced
selectively in degenerated proximal tubule and collecting
duct epithelia after injury and was present in both the
cytoplasm and nucleus, suggesting shuttling between these
two compartments. Interestingly, the upregulation of Id1
was associated with peritubular inflammation in mouse and
human nephropathies. In vitro, Id1 potentiated NF-jB
signaling and augmented RANTES expression in kidney
epithelial cells, which led to an enhanced recruitment of
inflammatory cells. Id1 also induced Snail1 expression and
triggered tubular epithelial dedifferentiation. In vivo, genetic
ablation of Id1 in mice reduced peritubular inflammation and
decreased tubular expression of RANTES following ureteral
obstruction. Mice lacking Id1 were also protected against
myofibroblast activation and matrix expression, leading
to a reduced total collagen deposition in obstructive
nephropathy. Thus, these results indicate that Id1 shuttles
between nucleus and cytoplasm, and promotes peritubular
inflammation and tubular epithelial dedifferentiation,
suggesting that these two events are intrinsically coupled
during renal fibrogenesis.
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Renal tubulointerstitial fibrosis is often regarded as the
final outcome of a wide range of progressive chronic kidney
diseases. The pathogenesis of tubulointerstitial fibrosis is
characterized by chronic peritubular inflammation, tubular
cell dedifferentiation, epithelial–mesenchymal transition
(EMT), and myofibroblast activation.1–4 These events ulti-
mately lead to an overproduction and excessive deposition of
extracellular matrix, and destruction of the fine architecture
of kidney parenchyma. It is generally believed that after a
variety of insults, the injured tubular epithelia produce and
secrete a host of chemokines, which trigger peritubular
infiltration of inflammatory cells.5–8 The inflamed milieus, in
turn, set up local microenvironment with high level of
fibrogenic cytokines that drives epithelial cell dedifferentia-
tion, EMT, and tubular atrophy.9–12 In many respects,
inflammatory infiltration and EMT constitute a vicious
circuit of peritubular inflammation, tubular cell dedifferen-
tiation, and interstitial fibrosis.10,13 However, whether
peritubular inflammation and EMT are intrinsically coupled
at molecular level is enigmatic.
Tubular EMT is an orchestrated, highly regulated process
in which tubular cell dedifferentiation, characterized by
loss of the epithelial cell adhesion receptor E-cadherin, is an
early event.14,15 Using gene expression microarray profiling,
we previously identified the inhibitor of differentiation-1
(Id1), a dominant negative antagonist of the basic helix–
loop–helix transcription factors,16 as a major trigger for
tubular cell dedifferentiation after injury. Id1 expression is
rapidly induced in the obstructed kidneys as early as 1 day
after unilateral ureteral obstruction (UUO).17 Ectopic
expression of Id1 in tubular epithelial cells represses the
expression of E-cadherin and tight-junction protein zonula
occludens-1 (ZO-1). Mechanistically, Id1 physically binds
to the basic helix–loop–helix transcription factor HEB,
and sequesters its ability to trans-activate E-cadherin
promoter.16–18 Id1 protein in the obstructed kidneys is
selectively upregulated in the degenerated tubules with a
dilated lumen, consistent with its role in mediating tubular
epithelial cell dedifferentiation.17 Somewhat surprisingly, Id1
is predominantly localized in the cytoplasm of the injured
kidney epithelial cells in vivo, as demonstrated by an indirect
immuofluorescence staining.17 This seems contradictory to
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its perceived function as a nuclear transcriptional antagonist
that represses E-cahderin and ZO-1 gene expression. This
paradox prompted us to further investigate the subcellular
localization of Id1 and to explore any unrecognized functions
of this protein in the pathogenesis of renal fibrosis.
Here, we show that Id1 is present in both the nucleus and
cytoplasm of tubular epithelial cells, and it undergoes nucleo-
cytoplasmic shuttling. In addition to acting as a transcrip-
tional antagonist in the nucleus, cytoplasmic Id1 is able to
promote NF-kB signaling and chemokine expression, and
facilitate peritubular inflammation. Mice with Id1 deficiency
are protected against renal inflammatory infiltration and
interstitial fibrosis. Our results establish that Id1, as a single
molecule, concomitantly promotes both epithelial cell
dedifferentiation and peritubular inflammation, thereby
providing an intrinsic, molecular link between two patho-
genic events in renal fibrogenesis.
RESULTS
Tubular segment-specific induction of Id1 in the fibrotic
kidneys
Earlier studies indicate that Id1 is specifically induced in
renal tubular epithelia after obstructive injury by immuo-
fluorescence staining.17 To further identify the tubular
segments that express Id1, we carried out double immuno-
staining for Id1 and various segment-specific tubular
markers. As shown in Figure 1, co-localization of Id1 and
aquaporin-1 (proximal tubular marker) was clearly evident
in the obstructed kidneys at 7 days after UUO, suggesting a
proximal tubule-specific induction of Id1 after kidney injury.
Of note, no or little Id1 staining was observed in normal
kidneys of the sham-operated mice (data not shown), as pre-
viously reported.17 Interestingly, there was no co-localization of
Id1 and Tamm–Horsfall glycoprotein (THP), also known as
uromodulin, a marker for the cortical thick ascending limb of
the loop of Henle. Similarly, Id1 was not found in the distal
convoluted tubules of the obstructed kidneys, as it did not co-
localize with thiazide-sensitive NaCl cotransporter, a specific
marker for that tubular segment (Figure 1). Id1, however, was
co-stained with renal collecting duct marker, fluorescein-
labeled Dolichos biflorus agglutinin (Figure 1). Together, it
becomes clear that Id1 induction in the fibrotic kidneys takes
place in a tubular segment-specific fashion.
Id1 was induced in cultured human proximal tubular
epithelial cells (HKC-8) in vitro after incubation with trans-
forming growth factor (TGF)-b1, as previously reported,17
suggesting that proximal tubular cells in vitro can recapitulate
in vivo responses to injury. In view of the in vivo data
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Figure 1 | Inhibitor of differentiation-1 (Id1) is induced in a tubular segment-specific fashion after injury. Immunofluorescence
staining demonstrated Id1 (red) and various tubular markers (green) in the obstructed kidneys at 7 days after unilateral ureteral obstruction.
No or little Id1 expression was detected in the sham-operated normal kidneys (data not shown). Segment-specific tubular markers used are
as follows: proximal tubule, aquaporin-1 (AQP1); cortical thick ascending limb, Tamm–Horsfall glycoprotein (THP); distal tubule, thiazide-
sensitive NaCl cotransporter (TSC)/NCC; and collecting duct, fluorescein-labeled Dolichos biflorus agglutinin (DBA). Boxed areas are enlarged.
Arrowheads indicate Id1-positive tubules. Bar¼ 50 mm.
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(Figure 1), we also examined whether TGF-b1 regulates Id1
expression in renal collecting duct epithelia as well in vitro.
To this end, mouse inner medullary collecting duct epithelial
cells (mIMCD-3) were incubated with TGF-b1, and then
assessed for Id1 expression. As shown in Supplementary
Figure S1 online, TGF-b1 induced Id1 mRNA and protein
expression in mIMCD-3 cells as well, as demonstrated by
real-time reverse transcriptase polymerase chain reaction
(RT-PCR) and western blot analyses, respectively.
Id1 undergoes nucleocytoplasmic shuttling
Immunostaining revealed that Id1 was localized predomi-
nantly in the cytoplasm of renal tubular epithelia after
obstructive injury (Figure 1). To further clarify this issue, we
utilized immunohistochemical staining, an approach with
better morphological resolution, to examine Id1 subcellular
localization. As shown in Figure 2a and b, Id1 was selectively
upregulated merely in the degenerated tubules with dilated
lumens, but not in the morphologically intact tubules after
UUO (Figure 2b). Higher magnification of the image
revealed a clear cytoplasmic and nuclear localization of Id1
protein in the injured tubular epithelium (Figure 2, arrows in
the enlarged box area).
To further address the Id1 subcellular localization, we used
a biochemical approach to detect cytoplasmic and nuclear
Id1 protein in HKC-8 cells after subcellular fractionation. As
shown in Figure 2c, Id1 protein was detectable in both
cytoplasm and the nuclei under basal conditions. On TGF-b1
stimulation, Id1 was markedly and transiently induced in
HKC-8 cells. Notably, the ratio of nuclear vs. cytoplasmic Id1
did not substantially change after TGF-b1 treatment.
Incubation of HKC-8 cells with leptomycin B, an inhibitor
of the nuclear export receptor CRM1 (chromosomal region
maintenance 1),19 also known as exportin 1, resulted in a
decrease of Id1 in the cytoplasm, accompanied by a concom-
itant increase in the nuclei (Figure 2c), suggesting that the
nuclear export receptor CRM1 mediates the cytoplasmic
localization of Id1 in tubular epithelial cells.
We also investigated the Id1 subcellular localization by
genetically tagging the Id1 with green fluorescent protein
(GFP). To this end, an expression vector encoding GFP–Id1
fusion protein was constructed and transiently transfected
into HKC-8 cells. Figure 2d showed both cytoplasmic
(Figure 2d, arrows) and nuclear (Figure 2d, arrowheads)
localization of GFP–Id1. Similarly, incubation with lepto-
mycin B also reduced the cytoplasmic localization of
GFP–Id1 fusion protein (Figure 2e). Collectively, these results
indicate that Id1 is localized in both the cytoplasm and
nuclei, and that there is a dynamic, CRM1-dependent
nucleocytoplasmic shuttling of Id1 in kidney tubular cells.
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Figure 2 | Inhibitor of differentiation-1 (Id1) is induced in both cytoplasm and nuclei of renal tubular epithelial cells in the injured
kidneys. (a, b) Immunohistochemical staining shows Id1 induction in the degenerated tubules after obstructive injury. (a) Sham
(b) unilateral ureteral obstruction for 7 days. Id1 induction was observed in the degenerated tubules with dilated lumen (*). Boxed area in
panel (b) was enlarged. Arrows indicate the tubular epithelial cells with both cytoplasmic and nuclear staining for Id1. Bar¼ 50mm.
(c) Western blot analyses demonstrate the presence of both cytoplasmic and nuclear Id1 protein. Human kidney tubular epithelial cells
(HKC-8) were treated with or without transforming growth factor (TGF)-b1 (2 ng/ml) in the absence or presence of leptomycin B (LMB)
as indicated. Cytoplasmic and nuclear protein were prepared and immunoblotted with antibodies against Id1, histone H3, or actin,
respectively. The ratio of nuclear/cytoplasmic Id1 (n/c ratio) was calculated and presented in the bottom of panel c. (d) Subcellular
localization of the green fluorescent protein (GFP)–Id1 fusion protein. HKC-8 cells were transfected with GFP-Id1 expression vector. Two
images in the same area with different exposure times are shown. Arrows show the cytoplasmic localization of GFP–Id1, while arrowheads
denote a predominant nuclear location. (e) Nucleocytoplasmic shuttling of GFP–Id1 fusion protein. HKC-8 cells were transfected with GFP-
Id1 expression vector, followed by incubation with or without LMB as indicated. Cytoplasmic and nuclear proteins were immunoblotted
with different antibodies as indicated. The ratio of nuclear/cytoplasmic Id1 (n/c ratio) was given in the bottom of panel e.
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Induction of Id1 is closely associated with peritubular
inflammation
The cytoplasmic localization of Id1 might imply novel
function of this protein, in addition to its role in regulating
gene transcription in the nucleus. To address this issue, we
first investigated Id1 regulation and its subcellular localiza-
tion in other models of chronic kidney disease. In an
accelerated mouse model of diabetic nephropathy, in which
diabetes was induced by streptozotocin in the nephrecto-
mized CD-1 mice,20 Id1 induction was observed specifically
in the degenerated, dilated renal tubules at 3 months after
streptozotocin injection, whereas morphologically normal
tubules were essentially negative for Id1 staining (Figure 3a
and b). This unique pattern of Id1 expression is compatible
with that in UUO mice (Figure 2b), suggesting that Id1
induction is associated with tubular cell dedifferentiation and
degeneration in this model as well. Of particular interest, there
was significant infiltration of inflammatory cells in the close
proximity to the Id1-positive tubules (Figure 3b, arrowhead).
To explore the relevance of Id1 induction to the patho-
genesis of chronic kidney diseases in humans, we examined
the Id1 expression in human kidney biopsies with different
nephropathies. As shown in Figure 3c, no or little Id1
staining was observed in human normal kidney. However,
substantial induction of Id1 was found in the renal tubules
of kidney biopsies from patients with various kidney dis-
orders. Notably, Id1 was localized in both the cytoplasm and
nuclei of tubular cells (Figure 3d–f, asterisks). Interestingly,
Id1-positive tubules were often surrounded by infiltrated
inflammatory cells (Figure 3d–f, arrowheads), suggesting
that Id1 may not only be instrumental in mediating tubular
cell dedifferentiation, but also could potentially have a role in
inciting peritubular infiltration of inflammatory cells.
Id1 potentiates NF-jB signaling and promotes RANTES
induction in tubular epithelial cells
The close association between Id1 induction and inflamma-
tory infiltration prompted us to investigate whether Id1
modulates renal inflammation and NF-kB signaling. As
shown in Figure 4a and b, Id1 overexpression enhanced
IkBa phosphorylation, an early event of NF-kB signaling that
takes place in the cytoplasm, in HKC-8 cells upon tumor
necrosis factor (TNF)-a stimulation. Id1 overexpression also
increased p65 NF-kB phosphorylation upon TNF-a stimula-
tion (Figure 4c and d). The magnitude of TNF-a-mediated
IkBa and p65 NF-kB phosphorylation were increased in
Id1-overexpressing cells. This led to an increased RANTES
(regulated on activation, normal T-cell expressed), also
known as CC-chemokine ligand 5, induction by TNF-a in
Id1-overexpressing tubular cells. As shown in Figure 5a
and b, TNF-a at 0.5 ng/ml induced substantial RANTES
expression in the Id1-overexpressing cells, compared with the
pcDNA3 mock-transfected controls. Using chemotaxis assay,
we further evaluated the significance of an increased tubular
expression of RANTES in recruiting inflammatory cells.
To this end, the supernatants of cell cultures were used to
assess their ability to attract THP-1 monocyte migration
across the Transwell filter. As shown in Figure 5c, conditioned
media derived from the Id1-overexpressing cells after TNF-a
stimulation were more potent in chemoattracting THP-1 cells,
compared with pcDNA3 controls. Consistently, RANTES was
selectively induced in the degenerated tubules in the
obstructed kidneys after UUO (Figure 5d), a pattern similar
to Id1 induction in this model (Figure 2b). Altogether, these
results suggest that Id1 sensitizes tubular epithelial cells to
produce pro-inflammatory RANTES, and facilitates peri-
tubular infiltration of inflammatory cells after injury.
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Figure 3 | Inhibitor of differentiation-1 (Id1) induction is closely associated with peritubular inflammation in chronic kidney
diseases. (a, b) Immunohistochemical staining shows a selective upregulation of Id1 in the degenerated, dilated tubules in mouse model of
diabetic nephropathy. (a) Control kidney; (b) diabetic kidney. Id1 was selectively induced in the dilated tubules (*) in the proximity of a
cluster of inflammatory cells (yellow arrowhead). Bar¼ 25 mm. (c–f) Id1 is induced in renal tubules of kidney biopsies from patients with
different nephropathies. (c) Control kidney; (d) focal and segmental glomerulosclerosis (FSGS); and (e, f) diabetic nephropathy. Asterisks (*)
denote the Id1-positive renal tubules. Yellow arrowheads show the infiltration of inflammatory cells.
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Id1 promotes tubular cell dedifferentiation by inducing
Snail1
Overexpression of Id1 leads to tubular cell dedifferentiation
characterized by loss of E-cadherin and ZO-1, as previously
reported,17 which is largely mediated by Id1-driven seques-
tration of transcription factor HEB in the nucleus. To further
delineate the mechanism by which Id1 promotes tubular cell
dedifferentiation, we examined its potential role in regulating
the expression of Snail1, a key transcription factor that
is essential for repressing E-cadherin and triggering
EMT.21,22 As shown in Figure 6a, ectopic expression of Id1
in HKC-8 cells induced Snail1 mRNA expression. Similarly,
Id1 also induced Snail1 protein expression in tubular epi-
thelial cells (Figure 6b). Interestingly, overexpression of
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Figure 4 | Ectopic expression of inhibitor of differentiation-1 (Id1) potentiates NF-jB signaling in kidney tubular epithelial cells.
(a, b) Id1 potentiates IkBa phosphorylation after tumor necrosis factor (TNF)-a stimulation. Id1-overexpressing cells and pcDNA3-mock
transfection controls were treated with TNF-a (5 ng/ml) for various periods of time. Cell lysates were immunoblotted with anti-phospho-
IkBa. (c, d) Id1 promotes p65 NF-kB phosphorylation after TNF-a stimulation. After treatment with TNF-a for various periods of time as
indicated, cell lysates were immunoblotted with antibodies against phospho-p65 or total p65, respectively. (a, c) Representative western
blots; (b, d) graphical presentation of the relative abundances (fold induction vs. the controls).
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Figure 5 | Ectopic expression of inhibitor of differentiation-1 (Id1) potentiates RANTES induction in tubular epithelial cells and
promotes monocyte chemotaxis. (a, b) Id1 potentiates RANTES expression in response to tumor necrosis factor (TNF)-a stimulation. HKC-8
cells transfected with either Id1 expression vector or pcDNA3 empty plasmid were treated with different doses of TNF-a for 24 h as
indicated. Cell lysates were immunoblotted with antibodies against RANTES or a-tubulin, respectively. (a) Representative western blot (b)
and quantitative data of RANTES expression in various groups are presented. *Po0.05 vs. pcDNA3 control (n¼ 3). (c) Id1 promotes the
chemoattraction of tubular epithelial HKC-8 cells to THP-1 monocytes in vitro. Id1-overexpressing HKC-8 cells and controls cells were treated
with TNF-a for 24 h. Conditioned media were collected for chemotaxis assay to assess their ability to attract THP-1 cells to migrate across the
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(d) Immunohistochemical staining shows an induction of RANTES protein in the degenerated tubules (*) in the obstructed kidneys at 7 days
after unilateral ureteral obstruction (UUO). Bar¼ 50 mm.
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Snail1 reciprocally induced Id1 expression (Figure 6c). These
results indicate that Id1 and Snail1 mutually induce each
other, thereby forming a positive feedback loop. As
previously reported,17,23 ectopic expression of either Id1
(Figure 6d) or Snail1 (Figure 6e) in HKC-8 cells suppressed
E-cadherin expression and triggered epithelial dedifferentia-
tion. Therefore, nuclear Id1, via binding to and sequestration
of HEB or/and inducing Snail1, has a critical role in
triggering tubular cell dedifferentiation (Figure 6f).
Ablation of Id1 reduces renal inflammation after
obstructive injury
To determine the role of Id1 in renal inflammation and
fibrogenesis in vivo, we employed a knockout mouse model
in which Id1 gene is genetically disrupted. Mice with Id1
deficiency (Id1/) developed normally and displayed no
overt abnormality in phenotypes, as previously reported.24
We first examined the expression of Id1 after obstructive
injury in the wild-type (Id1þ /þ ) and Id1 null mice (Id1/).
As shown in Figure 7a and b, ureteral obstruction induced
a significant increase in Id1 mRNA expression in the
obstructed kidney of wild-type mice, compared with sham
controls. As expected, no Id1 mRNA was detected in the
kidneys of Id1 null mice. Id1 deficiency did not significantly
affect the induction of Id3, another member of the Id family
proteins that shares a high structural similarity to Id1,16 in
the obstructed kidneys after UUO (Figure 7a and c).
To assess the potential effect of Id1 on renal inflam-
mation in vivo, we examined the peritubular infiltration of
inflammatory cells including CD3-positive T cells and
F4/80-positive monocytes/macrophages in the obstructed
kidneys, respectively. As shown in Figure 7d, compared with
sham controls, obstructive injury caused substantial T-cell
and macrophage infiltration in the obstructed kidneys, as
illustrated by immunohistochemical staining for CD3 and
F4/80 antigens. Id1 deficiency, however, significantly reduced
renal infiltration of T cells and macrophages (Figure 7d,
arrows). A computer-aided quantitative analysis also demon-
strated a reduction of inflammatory cell infiltration in Id1
null mice after UUO, compared with the wild-type controls
(Figure 7e and f).
Id1 deficiency decreases renal expression of inflammatory
mediators
We next examined the expression of RANTES, an important
inflammatory chemokine in the obstructed kidneys.25 As
shown in Figure 8a and b, quantitative real-time RT-PCR
analysis demonstrated a marked induction of RANTES mRNA
in the obstructive kidney, when compared with sham controls.
However, Id1 deficiency significantly inhibited RANTES
mRNA expression. We further investigated the expression of
TNF-a, a key inflammatory cytokine that is produced
primarily by the infiltrated cells, in the obstructed kidney
after UUO. Similarly, Id1 deficiency also reduced TNF-a
expression in the obstructed kidneys (Figure 8a and b).
We also investigated RANTES protein expression and its
localization by immunohistochemical staining. As shown in
Figure 8c, no or little RANTES protein was observed in
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Figure 6 | Inhibitor of differentiation-1 (Id1) promotes tubular cell dedifferentiation by inducing Snail1 and repressing E-cadherin
expression. (a, b) Overexpression of Id1 induces Snail1 mRNA (a) and protein (b) expression in tubular epithelial cells. HKC-8 cells
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vector (pcDNA3). (d, e) Either Id1 or Snail1 promotes tubular cell dedifferentiation by repressing E-cadherin expression. HKC-8 cells
were transfected with either Id1 expression vector (pcMV-Id1) or Snail1 expression vector (pHA-Snail1). Cell lysates were immunoblotted
with antibodies against E-cadherin or a-tubulin, respectively. C1 and C2 indicate individual cell clones after stable transfection. (f) Diagram
shows that Id1, as a single molecule, promotes tubular cell dedifferentiation and peritubular inflammation. EMT, epithelial–mesenchymal
transition.
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normal, sham-operated kidneys; however, RANTES was
induced in the degenerated, dilated renal tubular epithelium
in the obstructed kidney at 7 days after UUO. Consistent with
the mRNA data, Id1 deficiency also reduced RANTES protein
expression in the obstructed kidneys (Figure 8c and d).
Id1 deficiency inhibits myofibroblast activation and matrix
expression, and reduces renal fibrosis
Finally, we assessed the effects of Id1 deficiency on matrix
production and renal fibrosis in obstructive nephropathy. To
this end, we first examined the effects of Id1 deficiency on the
activation of myofibroblasts, the principal matrix-producing
cells in the fibrotic kidney, after obstructive injury.26–28 As
shown in Figure 9a and b, ureteral obstruction induced a
marked increase in the expression of a-smooth muscle actin,
the molecular signature of myofibroblasts. However, Id1 deficiency
reduced renal a-smooth muscle actin expression. Similar results
were obtained when using an indirect immunofluorescence
staining for a-smooth muscle actin (data not shown).
Figure 9c–e shows the expression of type I and type III
collagen mRNA in the obstructed kidneys after UUO. As
expected, marked induction of type I and type III collagen
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Figure 7 |Genetic ablation of inhibitor of differentiation-1 (Id1) reduces the infiltration of T cells and monocytes/macrophages
in obstructive nephropathy. (a–c) Reverse transcriptase polymerase chain reaction (RT-PCR) analysis shows Id1 and Id3 mRNA expression
in wild-type and Id1 knockout mice after unilateral ureteral obstruction (UUO). Numbers denote each individual mouse in a given group.
(a) Representative RT-PCR data; (b, c) quantitative data of Id1 (b) and Id3 (c) mRNA levels. (d) Representative micrographs show the
infiltration of CD3-positive T cells and F4/80-positive monocytes/macrophages in the obstructive kidneys of Id1 knockout mice and their
control littermates. Kidney sections were stained with antibody against CD3 or F4/80 antigens. Yellow arrows show the infiltration of
inflammatory cells. Bar¼ 25 mm. (e, f) Quantitative determination of the (e) CD3-positive T cells and (f) F4/80-positive macrophages in Id1
null mice and their control littermates at 7 days after UUO. *Po0.05 (n¼ 6).
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mRNA was observed at 7 days after ureteral obstruction in
wild-type mice, when compared with their sham controls.
However, ablation of Id1 significantly reduced type I and type
III collagen mRNA expression (Figure 9c–e). A collagen-
specific Picrosirius Red staining also revealed a marked
increase in collagen deposition after obstructive injury in
wild-type mice, which was reduced in Id1 null mice (Figure
9f). Quantitative determination of renal hydroxyproline
content also confirmed a reduced collagen accumulation in
Id1 null mice (Figure 9g). Together, these results indicate that
Id1 deficiency inhibits myofibroblast activation, attenuates
matrix production, and mitigates renal fibrosis in obstructive
nephropathy.
DISCUSSION
The linkage between inflammation and renal fibrosis has long
been established,29–31 and is also consistent with pathohisto-
logical evidence, as fibrotic foci in the injured kidneys are
typically instigated and encircled by inflammatory infiltrates.
The classical view on the connection of inflammation/fibrosis
is thought to be mediated by a paracrine fashion, in which
inflammatory cells secrete profibrotic cytokines that act on
resident fibroblasts and tubular cells to promote fibrogen-
esis.32,33 In this study, we demonstrate an intrinsic connec-
tion between inflammatory signal and EMT within the same
tubular cells at molecular levels. Id1 is selectively upregulated
in the degenerated proximal tubules and collecting ducts, and
is present in both the cytoplasm and nucleus. While nuclear
Id1 promotes tubular cell dedifferentiation by transcription-
ally repressing E-cadherin and ZO-1 expression,17 cytoplas-
mic Id1 potentiates NF-kB signaling and pro-inflammatory
RANTES expression, and facilitates peritubular infiltration of
inflammatory cells. These studies have clearly established that
Id1, as a single molecule, intrinsically couples inflammation
and tubular dedifferentiation, two important pathogenic
events in renal fibrogenesis.
Id1 is the prototype of a family of transcriptional
antagonists consisting of four members (Id1–Id4), each of
them with distinct expression pattern.16 Both Id1 and Id3 are
induced in the fibrotic kidneys after obstructive injury, and
genetic ablation of Id1 does not substantially affect Id3
induction in mice (Figure 6). We previously identified Id1 as
an important player in mediating cell dedifferentiation of
renal tubular epithelium, the early event of tubular EMT in
the fibrotic kidneys.17 As Id1 lacks the basic DNA-binding
domain but retains the ability to interact with HEB, such an
Id1/HEB heterodimeric complex formation sequesters the
ability of HEB to bind to the E-boxes in the E-cadherin gene
promoter.17 In this manner, Id1 acts as a dominant negative
inhibitor and blocks the HEB-mediated E-cadherin and ZO-1
expression, leading to epithelial cell dedifferentiation.17 This
assumption is consistent with and supported by the
characteristic pattern of Id1 induction, in which Id1 is
exclusively upregulated in the degenerated tubules with a
dilated lumen in various kinds of nephropathies in mice and
humans (Figures 2 and 3). Of interest, the present study
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Figure 8 | Inhibitor of differentiation-1 (Id1) deficiency reduces RANTES and tumor necrosis factor (TNF)-a expression in obstructive
nephropathy in vivo. (a, b) Reverse transcriptase polymerase chain reaction (RT-PCR) results show that Id1 deficiency decreased renal
RANTES and TNF-a mRNA expression at 7 days after unilateral ureteral obstruction (UUO). (a) Representative RT-PCR data; (b) graphic
presentation of relative RANTES and TNF-a mRNA levels detected by quantitative real-time polymerase chain reaction. *Po0.05 (n¼ 6).
(c, d) RANTES is induced in the degenerated tubules of obstructed kidneys at 7 days after UUO, which is attenuated in Id1 knockout
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further reveals that Id1 is also able to induce the expression
of Snail1 (Figure 6), a master transcription factor that not
only suppresses E-cadherin but also induces the expression
of mesenchymal genes.21,23,34 Furthermore, Id1 and Snail1
mutually induce each other (Figure 6), leading to the
formation of a positive feedback loop. Taken together,
these results indicate that Id1, as its name implied, triggers
tubular epithelial cell dedifferentiation by specifically
repressing E-cadherin via binding to and sequestration
of HEB, and inducing Snail1 expression (Figure 6f), which
apparently takes place in the nucleus of tubular epithelial
cells.
Subcellular distribution of Id1 protein, however, appears
inconsistent with its perceived function as a transcriptional
antagonist, because it is largely localized in the cytoplasm of
renal tubular epithelium in vivo. The cytoplasmic localization
of Id1 is confirmed by multiple approaches, including
immunohistochemical staining, cellular fractionation, and
direct visualization of GFP-tagged Id1 fusion protein.
Therefore, it is highly unlikely that this pattern of Id1
subcellular distribution is caused by technical shortcomings
such as nonspecific staining. Furthermore, treatment with the
nuclear export inhibitor leptomycin B reveals a nuclear
retention of Id1, suggesting a CRM1/exportin-dependent
nuclear export of Id1 at work in tubular cells (Figure 2). Such
a nucleocytoplasmic shuttling of Id1 is also observed in
human umbilical vein endothelial cells when cultured on
Matrigel, and it is regulated by protein kinase A.35 Whether,
and how, this nucleocytoplasmic shuttling of Id1 in tubular
epithelial cells is regulated remain to be elucidated; never-
theless, it might not be controlled by TGF-b1, as the ratio of
nuclear/cytoplasmic Id1 remains constant after TGF-b1
incubation in HKC-8 cells, despite an elevated level of total
cellular Id1 in this setting.
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muscle actin (a-SMA) expression in the obstructed kidneys after unilateral ureteral obstruction (UUO). Kidney lysates were immunoblotted
with specific antibodies against a-SMA and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), respectively. (a) Representative western
blot and (b) quantitative data of a-SMA expression in various groups are presented. *Po0.05 (n¼ 6). (c–e) Id1 deficiency inhibits matrix
gene expression in obstructive nephropathy. (c) Representative reverse transcriptase polymerase chain reaction analysis of renal mRNA
levels of type I and type III collagen in different groups as indicated. Numbers denote each individual mouse in a given group; (d, e)
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888 Kidney International (2012) 81, 880–891
or ig ina l a r t i c l e Y Li et al.: Id1 couples tubular dedifferentiation and inflammation
One of the novel findings in this study is the identification
of Id1 as an important regulator of peritubular inflammation
after renal injury. This notion is substantiated by several
lines of evidences. First, there is a close proximity between
inflammatory infiltrates and the Id1-positive tubules in the
diseased kidneys (Figure 3). More importantly, ectopic
expression of Id1 potentiates IkBa phopshorylation and
p65 NF-kB activation in tubular cells, and promotes
RANTES expression after TNF-a stimulation. Consistently,
conditioned media derived from Id1-overexpressing cells
facilitate the recruitment and infiltration of inflammatory
cells in chemotaxis assay (Figure 5c). Furthermore, genetic
ablation of Id1 protects the kidneys against inflammatory
infiltration of T cells and macrophages after obstructive
injury (Figure 7). It should be noted that previous studies
have shown that Id1 promotes cell survival in prostate cancer
and breast cancer cells, and induces the proliferation of
cochlear sensory epithelial cells via NF-kB activation.36–38 Id1
is also reported to potentiate NF-kB activation in a T-cell
line, leading to overproduction of cytokines such as TNF-a.39
These studies further strengthen the intrinsic connection
between Id1 and NF-kB activation, although the molecular
details remain to be elucidated. Of note, because IkBa
phosphorylation is an early event in NF-kB signaling that
takes place in the cytoplasm, this implies that the promotion
of NF-kB signaling is operated presumably by cytoplasmic
Id1. Along this line, it becomes clear that Id1 possesses two
distinct functions, dependent on its subcellular localization.
While nuclear Id1 induces tubular cell dedifferentiation by
repressing E-cadherin expression via sequestering HEB and
inducing Snail1, cytoplasmic Id1 is able to promote renal
inflammation by potentiating NF-kB signaling and chemo-
kine expression. Therefore, Id1, acting on distinct signal
pathways in different subcellular compartments, intrinsically
couples tubular cell dedifferentiation and peritubular inflam-
mation (Figure 6f).
Renal fibrogenesis usually instigates focally in the
proximity of microvasculature, an inflammatory and fibrotic
microenvironment, before progressing into widespread tissue
fibrosis. What constitutes the molecular basis of this fibrotic
niche is poorly understood. Our studies suggest that Id1 is
well suited to serve as a major and integral element of the
fibrotic niche in diseased kidneys after injury. Id1 is induced
rapidly and selectively in the degenerated tubules, and
it intrinsically connects tubular cell dedifferentiation and
peritubular inflammation. Therefore, Id1 is instrumental in
creating a focal, inflammatory, and fibrotic microenviron-
ment, which further drives fibrogenic responses. As illus-
trated in Id1 null mice, targeting Id1 could be beneficial
in preserving tubular cell integrity, reducing peritubular
inflammation, and ameliorating renal fibrogenesis.
MATERIALS AND METHODS
Cell culture and treatment
Human proximal tubular epithelial cell line (clone-8) (HKC-8) was
provided by Dr L Racusen of Johns Hopkins University. Mouse
inner medullary collecting duct epithelial cells (mIMCD-3) were
obtained from American Type Culture Collection (ATCC; Manassas,
VA).40 Cells were cultured in Dulbecco’s modified Eagle’s medium–-
Ham’s F12 medium supplemented with 10% fetal bovine serum.
HKC-8 cells were seeded atB70% confluence in complete medium
containing 10% fetal bovine serum. Twenty-four hours later, the
cells were changed to serum-free medium and incubated for 16 h.
Cells were then treated with recombinant human TNF-a (R & D
Systems, Minneapolis, MN) for various periods of time at the
concentration of 5 ng/ml except otherwise indicated. The cells were
then collected at different time points for western blot analysis.
Serum-starved mIMCD-3 cells were treated with TGF-b1 (2 ng/ml)
for various periods of time as indicated, and then collected for real-
time RT-PCR and western blot analyses. For some studies, cells were
transfected with Id1 expression vector (pcMV-Id1), GFP-tagged Id1
expression vector (pGFP-Id1), or Snail1 expression vector (pHA-
Snail1) by using Lipofectamine 2000 reagent (Invitrogen, Carlsbad,
CA). Id1 expression vector (pcMV-Id1) was described previously.17
Construction of the GFP-tagged Id1 expression vector (pGFP-Id1)
was carried out by standard molecular cloning techniques, and its
correct sequences were confirmed by DNA sequencing at the
University of Pittsburgh Biomedical Research Support Facilities.
Cellular fractionation
For preparation of nuclear protein, HKC-8 cells were washed twice
with cold phosphate-buffered saline and scraped off the plate with
a rubber policeman. After centrifugation, cell pellets were resus-
pended in Buffer A (10mmol/l HEPES pH 7.9, 1.5mmol/l MgCl2,
10 nmol/l KCl, 0.5% NP-40, and 1% protease inhibitor cocktail
(Sigma, St Louis, MO)) and lysed with homogenizer. Cell nuclei
were collected by centrifugation at 5000 r.p.m. for 15min, and the
supernatants were saved as cytoplasmic preparation. After washing
with Buffer B (10mmol/l HEPES pH 7.9, 1.5mmol/l MgCl2,
10 nmol/l KCl and 1% protease inhibitor cocktail), nuclei were lysed
in sodium dodecyl sulfate sample buffer.41
Animal model
Colonies of homozygous Id1 knockout (Id1/) and wild-type
(Id1þ /þ ) mice were described previously.24 A routine polymerase
chain reaction protocol was used for genotyping of tail DNA
samples with following primers: 50-TCCTGCAGCATGTAATCG
AC-30, 50-GACGTGCTACTTCCATTTGTCA-30, and 50-GAGACCC
ACTGGAAAGGACA-30, which yielded 344 and 540-bp bands for the
wild-type and mutated alleles, respectively. The experiments were
performed on male Id1/ and Id1þ /þ mice with identical genetic
backgrounds and with an average age of 8 weeks. There was no statis-
tical difference in the body weight of Id1/ and Id1þ /þ mice at the
time of the experiments. UUO was performed using an established
procedure, as described elsewhere.42 Mice were killed at day 7 after
surgery, and kidneys were removed. One part of the kidney was fixed
in 10% phosphate-buffered formalin, followed by paraffin embedding
for histological and immunohistochemical studies. Another part was
immediately frozen in Tissue-Tek OCT compound (Sakura Finetek,
Torrance, CA) for cryosection. The remaining kidneys were snap
frozen in liquid nitrogen and stored at 801C for extraction of RNA
and protein. All animal studies were approved by the Institutional
Animal Care and Use Committee at the University of Pittsburgh.
Human tissue samples
Human kidney specimens were obtained from diagnostic renal
biopsy performed at the University of Pittsburgh Medical Center.
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As normal controls, non-tumor kidney tissue from the patients who
had renal cell carcinoma and underwent nephrectomy was used.
Studies involving human tissues were approved by the Institutional
Review Board at the University of Pittsburgh.
Western blot analysis
Western blot analysis for specific protein expression was performed
essentially according to an established procedure.17 The primary
antibodies used were as follows: anti-RANTES (sc-1410), anti-Id1
(sc-488), and anti-actin (sc-1616) (Santa Cruz Biotechnology,
Santa Cruz, CA), anti-phospho-IkBa (Ser32/36), anti-phospho-p65
NF-kB (Ser536), and anti-p65 NF-kB (Cell Signaling Technology,
Beverly, MA), anti-Snail1 (ab17732), anti-histone H3 (Abcam,
Cambridge, MA), anti-E-cadherin (#610182; BD Transduction,
San Jose, CA) anti-a-smooth muscle actin (clone 1A4), anti-a-
tubulin (T9026) (Sigma), and anti-GAPDH (Ambion, Austin, TX).
Quantification was performed by measuring the intensity of the
signals with the use of NIH Image analysis software.
Quantitative real-time RT-Polymerase chain reaction analysis
Total RNA was extracted using TRIzol RNA isolation system
(Invitrogen). The first strand of cDNA was synthesized using 2 mg
of RNA in 20 ml of reaction buffer by reverse transcription using
AMV-RT (Promega, Madison, WI) and random primers at 421C
for 30min. Quantitative real-time RT-PCR was performed on ABI
PRISM 7000 Sequence Detection System (Applied Biosystems,
Foster City, CA), as described previously.22 The PCR reaction
mixture in a 25 ml volume contained 12.5 ml 2 SYBR Green PCR
Master Mix (Applied Biosystems), 5 ml diluted RT product (1:10),
and 0.5 mmol/l sense and antisense primer sets. The sequences of the
primer pairs were given in Supplementary Table S1 online. PCR
reaction was run by using standard conditions. The mRNA levels of
various genes were calculated after normalizing with b-actin. Some
polymerase chain reaction products were also size fractionated on a
1.0% agarose gel and detected by ethidium bromide staining.
Immunofluorescence staining
Indirect immunofluorescence staining was performed using an
established procedure.17,43 Briefly, kidney cryosections were fixed
with cold methanol:acetone (1:1) for 10min at 201C. Following
blocking with 20% normal donkey serum in phosphate-buffered
saline buffer, the slides were incubated with the primary antibodies
against Id1 (sc-488), aquaporin-1 (sc-9878), THP (sc-19554) (Santa
Cruz Biotechnology), thiazide-sensitive NaCl cotransporter
(AB3553; Millipore, Billerica, MA), and fluorescein-labeled Dolichos
biflorus agglutinin (FL-1031; Vector Laboratories, Burlingame, CA).
To visualize the primary antibodies, slides were stained with cyanine
Cy2- or Cy3-conjugated secondary antibodies (Jackson Immuno-
Research Laboratories, West Grove, PA). Stained slides were viewed
with a Nikon Eclipse E600 Epi-fluorescence microscope equipped
with a digital camera (Nikon, Melville, NY).
Histology and immunohistochemical staining
Kidney sections were prepared at 4 mm thickness by a routine
procedure. Sections were stained with hematoxylin–eosin, periodic
acid–Schiff, and Picrosirius Red reagents by standard protocol.5
Immunohistochemical staining of kidney sections was performed by
an established protocol.4,5 In brief, paraffin-embedded sections were
stained with anti-Id1 (sc-488), anti-CD3 (sc-20047) (Santa Cruz
Biotechnology), anti-F4/80 (14-4801-82; eBioscience, San Diego,
CA), and anti-RANTES (500-P118; PeproTech, Rocky Hill, NJ)
antibodies using the M.O.M. immunodetection kit, according
to the protocol specified by the manufacturer (Vector Laboratories).
Slides were viewed with an Eclipse E600 microscope equipped with
a digital camera (Nikon). CD-3, F4/80, and RANTES staining
were semi-quantified by a computer-aided morphometric analysis
(MetaMorph; Universal Imaging, Downingtown, PA). Briefly, a grid
containing 117 (13 9) sampling points was superimposed onto
images of cortical high-power field ( 400). The number of grid
points overlying positive area (except tubular lumen and glomeruli)
was counted and expressed as a percentage of all sampling points.
For each kidney, five randomly selected, nonoverlapping fields were
analyzed in a blinded manner.
Chemotaxis assay
Chemotaxis assay was performed using a 24-well Transwell plate as
described previously.5 Human monocytic cell line (THP-1) (ATCC)
was maintained in RPMI-1640 medium supplemented with 10%
fetal calf serum. Cultured THP-1 cells (5 105 in 100 ml) were
added onto the upper chamber of the Transwell insert (5 mm
polycarbonate filter, Corning, Corning, NY). Id1-overexpressing
cell-conditioned media (0.5ml) were added in the lower chamber of
the Transwell. After incubation at 371C for 4 h, the number of cells
migrated to the lower chamber of the Transwell was counted. Data
are expressed as percentage of the migrated cells in total number of
input cells.
Quantitative determination of tissue hydroxyproline content
To quantitative measurement of collagen deposition in the kidney,
total tissue collagen was estimated by biochemical analysis
of the hydroxyproline in the hydrolysates extracted from kidney
samples. This assay is based on the observation that essentially all
the hydroxyproline in animal tissues is found in collagen. Briefly,
kidney samples were dried at 1101C for 48 h, and then accurately
weighed. Dry kidney was hydrolyzed in sealed, oxygen-purged
glass ampoules containing 2ml of 6N HCl at 1101C for 24 h.
Hydroxyproline content in the hydrolysates was chemically quanti-
fied according to the techniques previously described.12 Tissue
hydroxyproline content was expressed as mg per mg dry kidney
weight.
Statistical analyses
All data examined were expressed as mean±s.e.m. Statistical
analyses of the data were performed using SigmaStat software
(Jandel Scientific Software, San Rafael, CA). Comparison between
groups was made using one-way ANOVA, followed by Student–
Newman–Keuls test. Po0.05 was considered significant.
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